Establishment Labs Completes Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
An investigation examines malpractice lawsuits alleging cosmetic surgery chains failed to recognize and respond to serious postoperative complications, including infections and sepsis, sometimes with fatal outcomes.